ArticleBMC cancer2023

Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients.

Hélène Pluchart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.